- Home
- DAIO vs CLNN Comparison
DAIO vs CLNN Comparison
Compare DAIO & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAIO
- CLNN
- Stock Information
- Founded
- DAIO 1969
- CLNN 2012
- Country
- DAIO United States
- CLNN United States
- Employees
- DAIO N/A
- CLNN N/A
- Industry
- DAIO Electrical Products
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- DAIO Industrials
- CLNN Health Care
- Exchange
- DAIO Nasdaq
- CLNN Nasdaq
- Market Cap
- DAIO 22.0M
- CLNN 23.1M
- IPO Year
- DAIO N/A
- CLNN N/A
- Fundamental
- Price
- DAIO $2.76
- CLNN $4.25
- Analyst Decision
- DAIO Strong Buy
- CLNN Strong Buy
- Analyst Count
- DAIO 1
- CLNN 5
- Target Price
- DAIO $4.00
- CLNN $40.00
- AVG Volume (30 Days)
- DAIO 30.5K
- CLNN 147.3K
- Earning Date
- DAIO 07-24-2025
- CLNN 05-07-2025
- Dividend Yield
- DAIO N/A
- CLNN N/A
- EPS Growth
- DAIO N/A
- CLNN N/A
- EPS
- DAIO N/A
- CLNN N/A
- Revenue
- DAIO $21,846,000.00
- CLNN $350,000.00
- Revenue This Year
- DAIO $7.06
- CLNN N/A
- Revenue Next Year
- DAIO $5.39
- CLNN $1,941.87
- P/E Ratio
- DAIO N/A
- CLNN N/A
- Revenue Growth
- DAIO N/A
- CLNN N/A
- 52 Week Low
- DAIO $1.88
- CLNN $2.28
- 52 Week High
- DAIO $3.14
- CLNN $9.20
- Technical
- Relative Strength Index (RSI)
- DAIO 63.34
- CLNN 64.94
- Support Level
- DAIO $2.64
- CLNN $2.28
- Resistance Level
- DAIO $2.85
- CLNN $4.49
- Average True Range (ATR)
- DAIO 0.12
- CLNN 0.43
- MACD
- DAIO 0.01
- CLNN 0.21
- Stochastic Oscillator
- DAIO 79.61
- CLNN 73.78
About DAIO Data I/O Corporation
Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.